Reported Jun 20, 2012 · Terminated
Propofol Injectable Emulsion, 1%, (10mg/mL), packaged in a) 200 mg/20 mL, 5 Units x 20 mL Single patient infusion vials…
Hospira, Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Hospira, Inc. · 600 N Field Dr Bldg J45 · Lake Forest, IL · 60045
Is this the product you have?
- Propofol Injectable Emulsion, 1%, (10mg/mL), packaged in a) 200 mg/20 mL, 5 Units x 20 mL Single patient infusion vials per carton (NDC 0409-4699-30); b) 1 g/100 mL, 10 Units x 100 mL Single patient infusion vials per carton (NDC 0409-4699-24); Rx only, Hospira, Inc., Lake Forest, IL 60045, USA.
- Lot codes and dates
Lot #: a) 03440DJ*Exp 1MAR2013b) 07947DJExp 1JUL201310134DJExp 1OCT2013
- Note* the lot may be followed by 01
- Amount recalled
- a) 36,125 vials; b) 31,280 vials
Where it was sold
- Nationwide
Why it was recalled
Presence of Particulate Matter: A single visible particulate was observed in a retention sample bottles identified as stainless steel
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Hospira, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.